Efficacy and safety of trabectedin in metastatic uterine leiomyosarcoma: A retrospective multicenter study of the Spanish ovarian cancer research group (GEICO)

Objective: We assessed trabectedin in patients with advanced uterine leiomyosarcoma (uLMS) in real-life clinical practice given according to the marketing authorization. Methods: Thirty-six women from 11 tertiary hospitals across Spain who received trabectedin after anthracycline-containing regimen/...

ver descrição completa

Detalhes bibliográficos

Principais autores:	María Jesús Rubio, María José Lecumberri, Silvia Varela, Jesús Alarcón, María Eugenia Ortega, Lydia Gaba, Jaime Espinós, Julia Calzas, Pilar Barretina, Isabel Ruiz, Gloria Marquina, Ana Santaballa
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2020-08-01
Colecção:	Gynecologic Oncology Reports
Assuntos:	Uterine leiomyosarcoma Metastatic Trabectedin Efficacy GEICO
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2352578920300606
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!